Impact of expiratory strength training in amyotrophic lateral sclerosis

The level of effort, rather than muscle exercise intensity determines strength gain following a six-week training

AIM

This study investigated the effect of voluntary motor effort during a low-intensity (30% maximal voluntary contraction [MVC]) muscle exercise training program on increasing muscle strength.

MATERIALS AND METHODS

Eighteen young and healthy individuals were randomly assigned to one of three groups: high mental effort (HME), low mental effort (LME), or a no-training control (CTRL) group. Training lasted for 6weeks (15min/day, 5days/week). The participants' right-elbow flexor muscle strength was measured before and after the training program.

KEY FINDINGS

After training, the HME group gained 20.47±8.33% (P=0.01) strength while the LME and CTRL groups had negligible strength changes (1.89±0.96% and -3.27±2.61%, respectively; P>0.05) despite muscle contraction intensity (30% MVC) sustained during training was the same for the HME and LME groups. These results suggest that the level of effort involved in resistance exercise training plays a critical role in determining the amount of strength augmentation.

SIGNIFICANCE

The finding that high effort combined with low-level physical exercise training can significantly increase muscle strength has rehabilitation applications as many patients and frail older adults have difficulties in participating in high-intensity exercise training such as lifting heavy weights. High effort plus low-level muscle exercise might serve as a safe training regimen for effective muscle strengthening in vulnerable populations.

Respiratory management of patients with neuromuscular disease: current perspectives

Neuromuscular ventilatory weakness can be difficult to recognize because the symptoms can be nocturnal, nonspecific, or attributed to other conditions. The presence of respiratory muscle weakness suggests a number of possible heterogeneous conditions, including neurodegenerative, autoimmune, and genetic neuromuscular diseases. In some conditions, disease-modifying management exists, but in the absence of such intervention, supportive respiratory therapy can improve quality of life and survival. In this review, we discuss the differential diagnosis and diagnostic approach to chronic neuromuscular respiratory weakness. We also review the clinical assessment and management of respiratory failure in these conditions.

Respiratory training in an individual with amyotrophic lateral sclerosis

We examined the impact of expiratory muscle strength training on maximum expiratory pressure, cough spirometry, and disease progression in a 71‐year‐old male with amyotrophic lateral sclerosis. Maximum expiratory pressure declined 9% over an 8‐week sham training period, but subsequently improved by 102% following 8 weeks of expiratory muscle strength training. Improvements in cough spirometry and mitigated disease progression were also observed post expiratory muscle strength training. Improvements in maximum expiratory pressures were maintained 6 months following expiratory muscle strength training and were 79% higher than baseline data obtained 301 days prior. In this spinal‐onset amyotrophic lateral sclerosis patient, respiratory training improved subglottic air pressure generation and sequential cough generation.

Supportive and symptomatic management of amyotrophic lateral sclerosis

The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive and symptomatic care provided by a specialist multidisciplinary team can improve survival. The basis for supportive management is shifting from expert consensus guidelines towards an evidence-based approach, which encourages the use of effective treatments and could reduce the risk of harm caused by ineffective or unsafe interventions. For example, respiratory support using noninvasive ventilation has been demonstrated to improve survival and quality of life, whereas evidence supporting other respiratory interventions is insufficient. Increasing evidence implicates a causal role for metabolic dysfunction in ALS, suggesting that optimizing nutrition could improve quality of life and survival. The high incidence of cognitive dysfunction and its impact on prognosis is increasingly recognized, although evidence for effective treatments is lacking. A variety of strategies are used to manage the other physical and psychological symptoms, the majority of which have yet to be thoroughly evaluated. The need for specialist palliative care throughout the disease is increasingly recognized. This Review describes the current approaches to symptomatic and supportive care in ALS and outlines the current guidance and evidence for these strategies.